Bank of Nova Scotia
CVS icon

Bank of Nova Scotia’s CVS Health CVS Stock Holding History

Bank of Nova Scotia’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104M Buy
1,003,295
+370,777
+59% +$33.1M 0.16% 105
2026
Q1 		$45.4M Sell
632,518
-587,663
-48% -$45.3M 0.08% 185
2025
Q4 		$96.8M Buy
1,220,181
+307,372
+34% +$24.2M 0.14% 121
2025
Q3 		$68.8M Buy
912,809
+642,628
+238% +$44M 0.12% 141
2025
Q2 		$18.6M Sell
270,181
-438,097
-62% -$28.7M 0.04% 273
2025
Q1 		$48M Buy
708,278
+509,603
+257% +$30.5M 0.11% 160
2024
Q4 		$8.92M Buy
198,675
+17,526
+10% +$983K 0.02% 439
2024
Q3 		$11.4M Buy
181,149
+53,096
+41% +$3.1M 0.02% 333
2024
Q2 		$7.56M Sell
128,053
-191,550
-60% -$12M 0.01% 404
2024
Q1 		$25.5M Sell
319,603
-688,452
-68% -$52.6M 0.05% 233
2023
Q4 		$79.6M Buy
1,008,055
+760,166
+307% +$54.1M 0.15% 119
2023
Q3 		$17.3M Buy
247,889
+135,375
+120% +$9.59M 0.05% 242
2023
Q2 		$7.78M Buy
112,514
+14,737
+15% +$1.05M 0.02% 317
2023
Q1 		$7.27M Sell
97,777
-262,008
-73% -$22M 0.02% 329
2022
Q4 		$33.5M Sell
359,785
-54,542
-13% -$5.26M 0.09% 175
2022
Q3 		$39.5M Sell
414,327
-304,710
-42% -$30.2M 0.13% 137
2022
Q2 		$66.6M Buy
719,037
+85,877
+14% +$8.38M 0.16% 116
2022
Q1 		$64.1M Buy
633,160
+95,425
+18% +$10M 0.11% 164
2021
Q4 		$55.5M Buy
537,735
+43,885
+9% +$4.06M 0.08% 226
2021
Q3 		$41.9M Buy
493,850
+10,478
+2% +$878K 0.07% 233
2021
Q2 		$40.3M Sell
483,372
-1,075,734
-69% -$88.1M 0.07% 221
2021
Q1 		$117M Sell
1,559,106
-790,153
-34% -$57.6M 0.23% 100
2020
Q4 		$160M Buy
2,349,259
+1,173,062
+100% +$76.3M 0.34% 76
2020
Q3 		$68.7M Sell
1,176,197
-120,064
-9% -$7.47M 0.19% 113
2020
Q2 		$84.2M Buy
1,296,261
+1,160,705
+856% +$73.1M 0.29% 82
2020
Q1 		$8.04M Sell
135,556
-622,451
-82% -$41.6M 0.03% 343
2019
Q4 		$56.3M Buy
758,007
+382,588
+102% +$26.9M 0.14% 161
2019
Q3 		$22.4M Sell
375,419
-424,683
-53% -$25.2M 0.07% 237
2019
Q2 		$43.3M Buy
800,102
+98,647
+14% +$5.31M 0.18% 124
2019
Q1 		$37.8M Buy
701,455
+233,800
+50% +$14.4M 0.15% 143
2018
Q4 		$30.6M Buy
467,655
+257,072
+122% +$19.2M 0.14% 147
2018
Q3 		$16.6M Buy
210,583
+90,932
+76% +$6.5M 0.07% 229
2018
Q2 		$7.7M Sell
119,651
-31,868
-21% -$2.1M 0.04% 285
2018
Q1 		$9.43M Sell
151,519
-466,106
-75% -$33.4M 0.05% 292
2017
Q4 		$44.8M Buy
617,625
+89,353
+17% +$6.5M 0.2% 115
2017
Q3 		$43M Sell
528,272
-53,152
-9% -$4.2M 0.25% 97
2017
Q2 		$46.8M Sell
581,424
-4,214
-0.7% -$333K 0.25% 83
2017
Q1 		$46M Buy
585,638
+211,083
+56% +$16.9M 0.2% 104
2016
Q4 		$29.6M Buy
374,555
+31,947
+9% +$2.58M 0.15% 96
2016
Q3 		$30.5M Buy
342,608
+280
+0.1% +$26.4K 0.17% 78
2016
Q2 		$32.8M Buy
342,328
+40,905
+14% +$4.08M 0.19% 61
2016
Q1 		$31.3M Sell
301,423
-24,960
-8% -$2.43M 0.19% 66
2015
Q4 		$32M Buy
326,383
+254,752
+356% +$25M 0.16% 83
2015
Q3 		$6.92M Buy
71,631
+51,426
+255% +$5.41M 0.04% 164
2015
Q2 		$2.12M Buy
20,205
+851
+4% +$86.9K 0.01% 226
2015
Q1 		$2M Sell
19,354
-220
-1% -$22.3K 0.01% 232
2014
Q4 		$1.89M Buy
19,574
+385
+2% +$33.9K 0.01% 232
2014
Q3 		$1.53M Buy
19,189
+357
+2% +$28.1K 0.01% 248
2014
Q2 		$1.42M Buy
18,832
+1,200
+7% +$90.7K 0.01% 253
2014
Q1 		$1.32M Buy
17,632
+622
+4% +$43.9K 0.01% 283
2013
Q4 		$1.22M Sell
17,010
-23,115
-58% -$1.49M 0.01% 309
2013
Q3 		$2.28M Buy
40,125
+21,616
+117% +$1.29M 0.01% 218
2013
Q2 		$1.06M Buy
+18,509
New +$1.07M 0.01% 234

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of Nova Scotia's CVS Position: Q2 2026 in Review

Bank of Nova Scotia increased its CVS Health (CVS) stake by 59% in Q2 2026, buying an estimated $33.1M and bringing the position to 1,003,295 shares worth $104M. The position accounts for 0.16% of the portfolio, ranked #105.

Bank of Nova Scotia first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $160M in Q4 2020. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Bank of Nova Scotia held 1,003,295 shares of CVS Health worth $104M as of Q2 2026.
  • Bank of Nova Scotia bought 370,777 CVS Health shares in Q2 2026, an estimated $33.1M.
  • CVS Health made up 0.16% of Bank of Nova Scotia's portfolio in Q2 2026, its #105 holding.
  • Bank of Nova Scotia first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Bank of Nova Scotia's CVS Health position peaked at $160M in Q4 2020.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.